Qube Research & Technologies (QRT)
MBX

Qube Research & Technologies (QRT)’s MBX Biosciences MBX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,187
Closed -$513K – 4212
2026
Q1 		$513K Sell
17,187
-6,026
-26% -$205K ﹤0.01% 2732
2025
Q4 		$732K Buy
+23,213
New +$563K ﹤0.01% 2677

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MBX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of MBX Biosciences (MBX) in Q2 2026, closing a stake of 17,187 shares — an estimated $513K sold.

Qube Research & Technologies (QRT) first reported a position in MBX in Q4 2025 and held it in 2 quarters. The position peaked at $732K in Q4 2025. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining MBX Biosciences position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 17,187 MBX Biosciences shares in Q2 2026, an estimated $513K.
  • Qube Research & Technologies (QRT) first reported a position in MBX Biosciences in Q4 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s MBX Biosciences position peaked at $732K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.